ur Race to Health Equity (ORTHE) was launched with the bold ambition that together, we can create a world where the color of your skin is not a determinant of your access to care, quality of care or health outcomes. In alignment with Our Credo, commitment to Diversity, Equity, and Inclusion, and legacy of taking on the toughest health challenges, we are turning a moment into a movement to rebuild healthcare from a diverse perspective by supporting solutions that systemically address racial health equity.
Johnson & Johnson aspires to help eradicate racial and social injustice as a public health threat by eliminating health inequities for people of color. The Company commits $100 million over the next five years to invest and promote health equity solutions.
Events in recent years, as well as startling statistics on equity around the world, have kick-started long overdue conversations about the impact of systemic racism on health outcomes. Our approach to DEI is constantly evolving and growing to anticipate and address these urgent needs.
I envision a future where we have a more equitable healthcare system as a direct result of increased diversity within the healthcare workforce itself. Our Race to Health Equity is a catalyst for that vision. As the world’s largest healthcare company, progress can be achieved when we foster a health equity mindset across all elements of our business. Only then can we hope to create meaningful change in healthcare to better meet the needs of people of color. It starts with us.
Our long-standing commitment to diversity, equity, and inclusion gives us the foundation to drive sustainable change. We are accelerating and expanding our efforts to strengthen our inclusive culture and build a workforce that reflects the diversity of the patients and communities we serve.